In this issue:
- Encorafenib, cetuximab and chemotherapy in BRAF-mutant CRC
- Circulating tumour DNA analysis guiding adjuvant therapy in colon cancer
- Lymph node yield and long-term mortality risk in colon cancer
- KH903 + FOLFIRI in unresectable recurrent or metastatic CRC
- Early discontinuation of immunotherapy in mCRC
- Overall survival with sotorasib + panitumumab in KRAS G12C CRC
- Retifanlimab for metastatic SCC of the anal canal
- When should CRC screening begin?
- CRC incidence trends in younger vs older adults
- Geographic and age variations in mutational processes in CRC
Please login below to download this issue (PDF)